215 related articles for article (PubMed ID: 22420424)
21. Identification and characterization of an immunodominant 28-kilodalton Coxiella burnetii outer membrane protein specific to isolates associated with acute disease.
Zhang G; To H; Russell KE; Hendrix LR; Yamaguchi T; Fukushi H; Hirai K; Samuel JE
Infect Immun; 2005 Mar; 73(3):1561-7. PubMed ID: 15731054
[TBL] [Abstract][Full Text] [Related]
22. Mice immunized with bone marrow-derived dendritic cells stimulated with recombinant Coxiella burnetii Com1 and Mip demonstrate enhanced bacterial clearance in association with a Th1 immune response.
Xiong X; Meng Y; Wang X; Qi Y; Li J; Duan C; Wen B
Vaccine; 2012 Nov; 30(48):6809-15. PubMed ID: 23000126
[TBL] [Abstract][Full Text] [Related]
23. Comparison of four commercially available assays for the detection of IgM phase II antibodies to Coxiella burnetii in the diagnosis of acute Q fever.
Frangoulidis D; Schröpfer E; Al Dahouk S; Tomaso H; Meyer H
Ann N Y Acad Sci; 2006 Oct; 1078():561-2. PubMed ID: 17114777
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of specificity of indirect enzyme-linked immunosorbent assay for diagnosis of human Q fever.
Uhaa IJ; Fishbein DB; Olson JG; Rives CC; Waag DM; Williams JC
J Clin Microbiol; 1994 Jun; 32(6):1560-5. PubMed ID: 8077404
[TBL] [Abstract][Full Text] [Related]
25. Combined determination of Coxiella burnetii-specific immunoglobulin M (IgM) and IgA improves specificity in the diagnosis of acute Q fever.
Devine P; Doyle C; Lambkin G
Clin Diagn Lab Immunol; 1997 May; 4(3):384-6. PubMed ID: 9144382
[TBL] [Abstract][Full Text] [Related]
26. Comparison of two new in-house Latex Agglutination Tests (LATs), based on the DnaK and Com1 synthetic peptides of Coxiella burnetii, with a commercial indirect-ELISA, for sero-screening of coxiellosis in bovines.
Yadav JP; Malik SVS; Dhaka P; Kumar M; Sirsant B; Gourkhede D; Barbuddhe SB; Rawool DB
J Microbiol Methods; 2020 Mar; 170():105859. PubMed ID: 32027926
[TBL] [Abstract][Full Text] [Related]
27. Introduction to Measurement of Avidity of Anti-Coxiella burnetii IgG in Diagnosis of Q Fever.
Luciani L; L'Ollivier C; Million M; Amphoux B; Edouard S; Raoult D
J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31366688
[TBL] [Abstract][Full Text] [Related]
28. Q fever: persistence of antigenic non-viable cell residues of Coxiella burnetii in the host--implications for post Q fever infection fatigue syndrome and other chronic sequelae.
Marmion BP; Sukocheva O; Storm PA; Lockhart M; Turra M; Kok T; Ayres J; Routledge H; Graves S
QJM; 2009 Oct; 102(10):673-84. PubMed ID: 19556396
[TBL] [Abstract][Full Text] [Related]
29. [Endocarditis in Q fever: its serological diagnosis and variation in the Coxiella burnetii phase].
Pascual Velasco F
Med Clin (Barc); 1995 Apr; 104(16):639. PubMed ID: 7752721
[No Abstract] [Full Text] [Related]
30. [Laboratory diagnosis of Q-fever with the indirect immunofluorescence test].
Beslagić E; Hamzić S; Zvizdić S; Bajrović T; Velić R
Med Arh; 2002; 56(2):89-92. PubMed ID: 12014103
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of the sensitivity of selected serological tests and activity of Coxiella burnetii antigens in the diagnosis of Q fever].
Tylewska-Wierzbanowska S; Kruszewska D
Med Dosw Mikrobiol; 1991; 43(3-4):119-26. PubMed ID: 1823374
[TBL] [Abstract][Full Text] [Related]
32. Antibodies are generated during infection to Coxiella burnetii macrophage infectivity potentiator protein (Cb-Mip).
Seshu J; McIvor KL; Mallavia LP
Microbiol Immunol; 1997; 41(4):371-6. PubMed ID: 9159413
[TBL] [Abstract][Full Text] [Related]
33. Coxiella burnetii immunogenic proteins as a basis for new Q fever diagnostic and vaccine development.
Gerlach C; Škultéty Ľ; Henning K; Neubauer H; Mertens K
Acta Virol; 2017; 61(3):377-390. PubMed ID: 28854806
[TBL] [Abstract][Full Text] [Related]
34. Identification and cloning of immunodominant antigens of Coxiella burnetii.
Zhang G; Kiss K; Seshadri R; Hendrix LR; Samuel JE
Infect Immun; 2004 Feb; 72(2):844-52. PubMed ID: 14742528
[TBL] [Abstract][Full Text] [Related]
35. Isolation of Coxiella burnetii in patients with nonspecific febrile illness in South Korea.
Lee SH; Lee JH; Park S; Lee HK; Do Hwang S; Jeong HW; Heo JY; Lee YS
BMC Infect Dis; 2020 Jun; 20(1):421. PubMed ID: 32552663
[TBL] [Abstract][Full Text] [Related]
36. Study of cross-reaction between Coxiella burnetii and Legionella pneumophila using indirect immunofluorescence assay and immunoblotting.
Finidori JP; Raoult D; Bornstein N; Fleurette J
Acta Virol; 1992 Oct; 36(5):459-65. PubMed ID: 1364022
[TBL] [Abstract][Full Text] [Related]
37. Seroepidemiological and molecular investigation of spotted fever group rickettsiae and Coxiella burnetii in Sao Tome Island: A One Health approach.
Hsi TE; Hsiao SW; Minahan NT; Yen TY; de Assunção Carvalho AV; Raoult D; Fournier PE; Tsai KH
Transbound Emerg Dis; 2020 Jul; 67 Suppl 2():36-43. PubMed ID: 31231971
[TBL] [Abstract][Full Text] [Related]
38. Long-term persistence of Coxiella burnetii after acute primary Q fever.
Marmion BP; Storm PA; Ayres JG; Semendric L; Mathews L; Winslow W; Turra M; Harris RJ
QJM; 2005 Jan; 98(1):7-20. PubMed ID: 15625349
[TBL] [Abstract][Full Text] [Related]
39. Coxiella burnetii Epitope-Specific T-Cell Responses in Patients with Chronic Q Fever.
Scholzen A; Richard G; Moise L; Hartman E; Bleeker-Rovers CP; Reeves PM; Raju Paul S; Martin WD; De Groot AS; Poznansky MC; Sluder AE; Garritsen A
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331958
[TBL] [Abstract][Full Text] [Related]
40. Q fever as a cause of fever of unknown origin and thrombocytosis: first molecular evidence of Coxiella burnetii in Brazil.
Lemos ER; Rozental T; Mares-Guia MA; Almeida DN; Moreira N; Silva RG; Barreira JD; Lamas CC; Favacho AR; Damasco PV
Vector Borne Zoonotic Dis; 2011 Jan; 11(1):85-7. PubMed ID: 20569012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
